Alli Sparks Reevaluation Of OTC Weight-Loss Indication
This article was originally published in The Tan Sheet
Executive Summary
FDA will revisit its thinking about weight loss as an OTC indication as the agency decides whether to allow Xenical to be sold without a prescription